Table 1.
Diseases | Source | Exosomal miRNAs | Amounts | Effects of exosomal miRNAs | References |
---|---|---|---|---|---|
Oral squamous cell carcinoma | Hypoxic SCC-9 and CAL-27 | miR-21 | Up | CAL-27-derived exosomes was maily used in functinal experiments.Exosomal miR-21 induced prometastatic behaviors under hypoxia condition | [20] |
cisplatin-resistant HSC-3 and SCC-9 | miR-21 | Up | exosomes transferred miR-21 to OSCC parental cells and induced cisplatin resistance | [18] | |
HOC313-LM | miR-1246, miR-342–3p | Up | Increased the migration and invasion ability of HOC313-P cells. exosomal miR-1246 enhanced cell motility | [19] | |
SCC-9, CAL-27 | miR-29a-3p | up | promoted M2-subtype macrophages polarization via SOCS1/STAT6 signaling pathway | [21] | |
Primary cancer-associated fibroblasts | miR-34a-5p | Down | miR-34a-5p/AXL axis promoted OSCC progression, inducing the EMT to promote cancer cells metastasis | [53] | |
Saliva | miR-412-3p, miR-512-3p, miR-27a-3p, miR-373-3p and miR-494-3p, miR-302b-3p, miR-517b-3p | Up | Potentially be used in liquid biopsy; miR-302b-3p, miR-517b-3p expressed specifically only in samples from OSCC saliva | [59] | |
Serum | miR-21 | Closely associated with HIF-1a/HIF-2a expression, T stage, and lymph node metastasis | [20] | ||
Plasma | hsa-miR-19a, hsa-miR-512-3p, hsa-miR-27b, hsa-miR-20a, hsa-miR-28-3p, hsa-miR-200c, hsa-miR-223, hsa-miR-20b, hsa-miR-151-3p | Up | More reliable for evaluation of circulating tumor-miRNA expression than plasma | [63] | |
hsa-miR-22, hsa-miR-370, hsa-miR-139-5p, hsa-let-7e, hsa-miR-145-3p, hsa-miR-30c | Down | ||||
Primary Sjögren’s syndrome | EBV-infected B cells | ebv-miR-BART13-3p | Not shown | Decreased store operated Ca2+ entry and Ca2+-dependent activation of NFAT in SGECs | [89] |
Oral lichen planus | Saliva | miR-4484 | Up | Potential miRNA biomarker for OLP | [93] |
Plasma | miR-34a-5p, miR-130b-3p | Up | miR-34a-5p was positively correlated with the severity of OLP | [22] | |
miR-301b-3p | Down | Not shown | |||
Hand, foot and mouth disease | Serum | miR-16-5p | Up | Biomarkers for diagnose, and miR-671-5p may be used for subtyping HFMD | [98] |
miR-671-5p, miR-150-5p | Down | ||||
Oral leukoplakia | MSCs from human primary tissues | miR-8485 | Up | Promoted the proliferation, migration and invasion of DOK and SCC-15 cell lines | [68] |
Murine bone marrow-MSCs | miR-185 | Up* | Attenuated inflammation severity and decreased degree of dysplasia in the OPMD tissue | [69] | |
Periodontitis | LPS-stimulated periodontal ligament stem cells | miR‐155 | Up | Reducing the expression of Th17 and increasing the expression of Treg | [79] |
Up: the expression of miRNAs was upregulated in exosomes
Up*: the the expression of miRNAs in exosomes was upregulated by transfection
Down: the expression of miRNAs was down regulated in exosomes